These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 4278582)

  • 1. [Effect of antiadrenergic and antidopaminergic drugs on methamphetamine induced changes in motor activity and cerebral glycogen content of mice].
    Estler CJ
    Arzneimittelforschung; 1974 Aug; 24(8):1087-8. PubMed ID: 4278582
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antagonistic effect of beta-sympatholytics on methamphetamine-induced changes in the function and metabolism in brain].
    Estler CJ; Ammon HP
    Arzneimittelforschung; 1970 Jul; 20(7):908-9. PubMed ID: 5536056
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of receptor blocking drugs on the depletion of brain glycogen by amphetamine.
    Hutchins DA; Rogers KJ
    Br J Pharmacol; 1971 Nov; 43(3):504-13. PubMed ID: 4400527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification by two beta-adrenergic blocking drugs of the effects of methamphetamine on behaviour and brain metabolism of mice.
    Estler CJ; Ammon HP
    J Neurochem; 1971 May; 18(5):777-9. PubMed ID: 4401442
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inhibition of stimulatory effect of methamphetamine and morphine in mice by the modification of endogenous catecholamines].
    Strubelt O; Vogelberg W; Zetler G
    Arzneimittelforschung; 1970 Jan; 20(1):32-7. PubMed ID: 4392499
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of propranolol and dibenzyline on glycogenolytic effects of some biogenic amines in rat brain slices.
    Mrsulja BB
    Experientia; 1972 Sep; 28(9):1072-3. PubMed ID: 4353033
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of catecholamines, adrenergic substances and their blocking agents on the searching behavior of mice.
    Fischer E; Saavedra JM; Heller B
    Arzneimittelforschung; 1968 Jul; 18(7):780-6. PubMed ID: 5755819
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibitory effect of dihydroergocristine, phenoxybenzamine and propranolol on the hypermotility induced by low doses of ethyl alcohol in mice.
    Boada JN; Feria M; Serrano M; Darias V
    Arch Farmacol Toxicol; 1979 Aug; 5(2):117-22. PubMed ID: 119498
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of tetrabenazine on methamphetamine-induced hyperactivity in mice are dependent on order and time-course of administration.
    Kuribara H
    Pharmacol Biochem Behav; 1997 Jan; 56(1):9-14. PubMed ID: 8981603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?
    Jones CD; Bartee JA; Leite-Browning ML; Blackshear MA
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(4):15-22. PubMed ID: 17531156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of phenoxybenzamine on methamphetamine-induced changes in locomotor activity, oxygen consumption, body temperature and some metabolic parameters.
    Estler CJ
    Neuropharmacology; 1975 Oct; 14(10):779-83. PubMed ID: 1196474
    [No Abstract]   [Full Text] [Related]  

  • 12. [Methamphetamine stimulation in mice].
    Fähse C; Lietz W; Matthies H
    Acta Biol Med Ger; 1971; 26(6):1223-7. PubMed ID: 5153310
    [No Abstract]   [Full Text] [Related]  

  • 13. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
    Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
    Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAN-190, a possible specific antagonist for methamphetamine.
    Ginawi OT; Al-Majed AA; Al-Suwailem AK
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):122-7. PubMed ID: 15698535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.
    Albers DS; Sonsalla PK
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1104-14. PubMed ID: 8531070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of indolealkylamine manipulations on locomotor activity in rats.
    Jacobs BL; Eubanks EE; Wise WD
    Neuropharmacology; 1974 Jul; 13(7):575-83. PubMed ID: 4280024
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of pimozide and phenoxybenzamine on the motor hyperactivity of rats treated with nialamide and dopamine (author's transl)].
    Malec D; Kleinrok Z
    Ann Univ Mariae Curie Sklodowska Med; 1975; 30():109-12. PubMed ID: 1230064
    [No Abstract]   [Full Text] [Related]  

  • 18. Dual alteration of limbic dopamine D1 receptor-mediated signalling and the Akt/GSK3 pathway in dopamine D3 receptor mutants during the development of methamphetamine sensitization.
    Chen PC; Lao CL; Chen JC
    J Neurochem; 2007 Jan; 100(1):225-41. PubMed ID: 17101033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary cadmium exposure attenuates D-amphetamine-evoked [3H]dopamine release from striatal slices and methamphetamine-induced hyperactivity.
    Miller DK; Dopheide MM; Smith SM; Casteel SW
    Pharmacol Biochem Behav; 2005 Apr; 80(4):557-66. PubMed ID: 15820525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of 5-HT receptors in the development and expression of methamphetamine-induced behavioral sensitization: 5-HT receptor channel and binding study.
    Yoo JH; Cho JH; Yu HS; Lee KW; Lee BH; Jeong SM; Nah SY; Kim HC; Lee SY; Jang CG
    J Neurochem; 2006 Nov; 99(3):976-88. PubMed ID: 16942594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.